Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Results of Phase III BRAVO Trial Reinforce Unique Profile of Laquinimod for Multiple Sclerosis Treatment
Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis.
Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: Results of a 17-year longitudinal study.
Effect of IFN β-1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients.
Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis.
Breastfeeding and multiple sclerosis.
Adaptive myelination from fish to man.
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
Santhera's Phase III program with Catena®/Raxone® in Duchenne muscular dystrophy on track to deliver pivotal data early in 2Q 2014
One can prevent post-partum MS relapses by exclusive breast feeding: no.
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse-Remitting Multiple Sclerosis
Rituximab versus fingolimod after natalizumab in multiple sclerosis patients.
Genmab announces results of ofatumumab Phase II study in multiple sclerosis
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.
Rituximab product approval information - Licensing action
Teva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE® 20 mg/mL Case and Remand for Further Review
New data from ENDORSE show positive results continued over five years with TECFIDERA® (dimethyl fumarate) in a wide range of multiple sclerosis patients
Alemtuzumab benefits hard-to-treat MS patients
Multiple Sclerosis and Pregnancy: Current Considerations.
Rituximab and multiple sclerosis.
Neuropathology of white matter disease in Leber's hereditary optic neuropathy.
Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis.
Novantrone (mitoxantrone HCl) Injection February 2009
RTL therapy for multiple sclerosis: a Phase I clinical study.

Pages